Literature DB >> 26758533

Anticancer Potential and Molecular Targets of Pristimerin: A Mini- Review.

Bashir A Yousef, Hozeifa M Hassan, Lu-Yong Zhang1, Zhen-Zhou Jiang1.   

Abstract

Pristimerin, a natural triterpenoid isolated form Celastrus and Maytenus spp, has been shown to possess a variety of biological and pharmacological effects. Recently, pristimerin has attracted more attention, especially for its potential anticancer activities. The anticancer activities of pristimerin have been illustrated in various cancer cell lines and animal models. It has been found to inhibit in vitro and in vivo proliferation, survival, angiogenesis and metastasis of tumor cells. These activities have been attributed to its modulation of various molecular targets such as cyclins, apoptosis- related proteins, proteasome activity, reactive oxygen species, as well as NF-kB, AKT/mTOR and MAPK/ERK pathways. This mini-review discussed the cellular impact and animal studies of pristimerin treatment, with more attention on the various molecular targets of pristimerin. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.org.

Entities:  

Keywords:  Antitumor agents; NF-kB; natural compounds; pharmacological effects; pristimerin

Mesh:

Substances:

Year:  2017        PMID: 26758533     DOI: 10.2174/1568009616666160112105824

Source DB:  PubMed          Journal:  Curr Cancer Drug Targets        ISSN: 1568-0096            Impact factor:   3.428


  15 in total

1.  Functional evaluation of synthetic flavonoids and chalcones for potential antiviral and anticancer properties.

Authors:  Nelly Mateeva; Suresh V K Eyunni; Kinfe K Redda; Ucheze Ononuju; Tony D Hansberry; Cecilia Aikens; Anita Nag
Journal:  Bioorg Med Chem Lett       Date:  2017-04-13       Impact factor: 2.823

2.  MTDH/AEG-1 downregulation using pristimerin-loaded nanoparticles inhibits Fanconi anemia proteins and increases sensitivity to platinum-based chemotherapy.

Authors:  Jianling Bi; Sudartip Areecheewakul; Yujun Li; Shujie Yang; Yuping Zhang; Kareem Ebeid; Long Li; Kristina W Thiel; Jun Zhang; Donghai Dai; Aliasger K Salem; Kimberly K Leslie; Xiangbing Meng
Journal:  Gynecol Oncol       Date:  2019-08-30       Impact factor: 5.482

3.  Cytotoxic effect of Semialarium mexicanum (Miers) Mennega root bark extracts and fractions against breast cancer cells.

Authors:  Juan Maldonado-Cubas; Eduardo San Martin-Martínez; Cinthya Nathaly Quiroz-Reyes; Rocio Guadalupe Casañas-Pimentel
Journal:  Physiol Mol Biol Plants       Date:  2018-07-23

4.  Pristimerin Suppressed Breast Cancer Progression via miR-542-5p/DUB3 Axis.

Authors:  Shihuan Cheng; Zhihong Zhang; Cong Hu; Na Xing; Yan Xia; Bo Pang
Journal:  Onco Targets Ther       Date:  2020-07-07       Impact factor: 4.147

5.  Pristimerin Inhibits LPS-Triggered Neurotoxicity in BV-2 Microglia Cells Through Modulating IRAK1/TRAF6/TAK1-Mediated NF-κB and AP-1 Signaling Pathways In Vitro.

Authors:  Bin Hui; Liping Zhang; Qinhua Zhou; Ling Hui
Journal:  Neurotox Res       Date:  2017-11-08       Impact factor: 3.911

6.  Friedelin Synthase from Maytenus ilicifolia: Leucine 482 Plays an Essential Role in the Production of the Most Rearranged Pentacyclic Triterpene.

Authors:  Tatiana M Souza-Moreira; Thaís B Alves; Karina A Pinheiro; Lidiane G Felippe; Gustavo M A De Lima; Tatiana F Watanabe; Cristina C Barbosa; Vânia A F F M Santos; Norberto P Lopes; Sandro R Valentini; Rafael V C Guido; Maysa Furlan; Cleslei F Zanelli
Journal:  Sci Rep       Date:  2016-11-22       Impact factor: 4.379

7.  Cytotoxic Triterpenes from Salacia crassifolia and Metabolite Profiling of Celastraceae Species.

Authors:  Laila S Espindola; Renata G Dusi; Daniel P Demarque; Raimundo Braz-Filho; Pengcheng Yan; Heidi R Bokesch; Kirk R Gustafson; John A Beutler
Journal:  Molecules       Date:  2018-06-20       Impact factor: 4.411

8.  Pristimerin protects against inflammation and metabolic disorder in mice through inhibition of NLRP3 inflammasome activation.

Authors:  Qun Zhao; Yun Bi; Jian Guo; Ying-Xiang Liu; Jing Zhong; Long-Rui Pan; Yan Tan; Xian-Jun Yu
Journal:  Acta Pharmacol Sin       Date:  2020-09-28       Impact factor: 7.169

9.  Pristimerin Exacerbates Cellular Injury in Conditionally Reprogrammed Patient-Derived Lung Adenocarcinoma Cells by Aggravating Mitochondrial Impairment and Endoplasmic Reticulum Stress through EphB4/CDC42/N-WASP Signaling.

Authors:  Yubo Tang; Yiyan Lei; Shuai Huang; Zhangyan Li; Xiangtian Chen; Honghe Luo; Chao Cheng; Jie Chen; Xuenong Zou; Xiao Chen
Journal:  Oxid Med Cell Longev       Date:  2020-07-10       Impact factor: 6.543

10.  Friedelin in Maytenus ilicifolia Is Produced by Friedelin Synthase Isoforms.

Authors:  Thaís B Alves; Tatiana M Souza-Moreira; Sandro R Valentini; Cleslei F Zanelli; Maysa Furlan
Journal:  Molecules       Date:  2018-03-20       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.